|
| Issue Date | Title | Author(s) |
| 15-Dec-2020 | Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation | Ali, Marwa A; Menze, Esther ; Tadros, Marianne G; Tolba, Mai |
| Jun-2018 | Caffeic acid phenethyl ester guards against benign prostate hypertrophy in rats: Role of IGF-1R/protein kinase-B (Akt)/β-catenin signaling | Omar, Hany A; Tolba, Mai |
| 1-Jun-2017 | Caffeic acid phenethyl ester protects against glucocorticoid-induced osteoporosis in vivo: Impact on oxidative stress and RANKL/OPG signals | Tolba, Mai ; El-Serafi, Ahmed T; Omar, Hany A |
| Aug-2013 | Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects | Tolba, Mai ; Azab, Samar S; Khalifa, Amani E; Abdel-Rahman, Sherif Z; Abdel-Naim, Ashraf B |
| 2-Oct-2016 | Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, Protective Effects against Ischemia-reperfusion Injury and Drug Adverse Reactions | Tolba, Mai ; Omar, Hany A; Azab, Samar S; Khalifa, Amani E; Abdel-Naim, Ashraf B; Abdel-Rahman, Sherif Z |
| 18-Jul-2013 | Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells | Mosli, Hisham A; Tolba, Mai ; Al-Abd, Ahmed M; Abdel-Naim, Ashraf B |
| 2016 | The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells | Attia, Reem T; Tolba, Mai ; Trivedi, Ruchit; Tadros, Mariane G; Arafa, Hossam M M; Abdel-Naim, Ashraf B |
| 2021 | Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa | Mosi, Lydia; Sylverken, Augustina Angelina; Oyebola, Kolapo; Badu, Kingsley; Dukhi, Natisha; Goonoo, Nowsheen; Mante, Priscilla Kolibea; Zahouli, Julien; Amankwaa, Ebenezer Forkuo; Tolba, Mai ; Fagbamigbe, Adeniyi Francis; de Souza, Dziedzom Komi; Matoke-Muhia, Damaris |
| Dec-2014 | Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents | Abdelazeem, Ahmed H; Gouda, Ahmed M; Omar, Hany A; Tolba, Mai |
| Feb-2015 | Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids | Fares, Mohamed; Eldehna, Wagdy M; Abou-Seri, Sahar M; Abdel-Aziz, Hatem A; Aly, Mohamed H; Tolba, Mai |
| 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 2015 | Discovery of Potent Antiproliferative Agents Targeting EGFR Tyrosine Kinase Based on the Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine Scaffold | Aziz, Yasmine Mohamed Abdel; Said, Mohamed Mokhtar; El Shihawy, Hosam Ahmed; Tolba, Mai ; Abouzid, Khaled |
| 2023 | Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022 | Khan, Husain Yar; Bajbouj, Khuloud; Tolba, Mai |
| 2021 | Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer | Tolba, Mai ; Santa-Maria, Cesar A; Albini, Adriana; Chimusa, Emile R; Al-Ramadi, Basel K; Tolaney, Sara M |
| Sep-2019 | Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment | Omar, Hany A; El-Serafi, Ahmed T; Hersi, Fatema; Arafa, El-Shaimaa A; Zaher, Dana M; Madkour, Mohamed; Arab, Hany H; Tolba, Mai |
| Feb-2018 | Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders | Tolba, Mai ; Omar, Hany A |
| 15-May-2019 | The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers | Tolba, Mai ; Omar, Hany A; Hersi, Fatima; Nunes, Ane C F; Noreddin, Ayman M |
| Mar-2022 | Implications of WHO COVID-19 interim guideline 2020.5 on the comprehensive care for infected persons in Africa Before, during and after clinical management of cases | Fagbamigbe, Adeniyi Francis; Tolba, Mai ; Amankwaa, Ebenezer F; Mante, Priscilla Kolibea; Sylverken, Augustina Angelina; Zahouli, Julien Z B; Goonoo, Nowsheen; Mosi, Lydia; Oyebola, Kolapo; Matoke-Muhia, Damaris; de Souza, Dziedzom K; Badu, Kingsley; Dukhi, Natisha |
| 1-Sep-2023 | Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model | Abdeljalil, Somaya M; Wahdan, Sara A; Elghazaly, Hesham; Tolba, Mai |
| Jul-2022 | Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors | Sedky, Nada K; Hamdan, Alyaa A; Emad, Salma; Allam, Aya L; Ali, Mohamed; Tolba, Mai |
| 15-Jan-2015 | Leptin influences estrogen metabolism and accelerates prostate cell proliferation | Habib, Christine N; Al-Abd, Ahmed M; Tolba, Mai ; Khalifa, Amani E; Khedr, Alaa; Mosli, Hisham A; Abdel-Naim, Ashraf B |
| Jul-2020 | The natural flavonoid galangin ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Effect on Toll-like receptor 4, inflammation and oxidative stress | Gerges, Samar H; Tolba, Mai ; Elsherbiny, Doaa A; El-Demerdash, Ebtehal |
| 29-Jul-2016 | Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells | Youssef, Mohieldin M; Tolba, Mai ; Badawy, Noha N; Liu, Andrew W; El-Ahwany, Eman; Khalifa, Amani E; Zada, Suher; Abdel-Naim, Ashraf B |
| Oct-2021 | Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers | Tolba, Mai ; Elghazaly, H; Bousoik, E; Elmazar, M M A; Tolaney, S M |
| 1-May-2021 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells | Abdin, Shifaa M; Tolba, Mai ; Zaher, Dana M; Omar, Hany A |
| 2016 | OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53 | Omar, Hany A; Tolba, Mai ; Hung, Jui-Hsiang; Al-Tel, Taleb H |
| 2015 | Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts | Cross, Courtney E; Tolba, Mai ; Rondelli, Catherine M; Xu, Meixiang; Abdel-Rahman, Sherif Z |
| Dec-2014 | Potential targets of energy restriction mimetic agents in cancer cells | Omar, Hany A; Tolba, Mai ; Saber-Ayad, Maha M |
| 16-Oct-2015 | Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity | Tolba, Mai ; Abdel-Rahman, Sherif Z |
| 1-Dec-2020 | Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors | Tolba, Mai |
| 2021 | Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling | Baraka, Sarah A; Tolba, Mai ; Elsherbini, Doaa A; El-Naga RN ; Awad, Azza S; El-Demerdash, Ebtehal |
| 2021 | SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines | Badu, Kingsley; Oyebola, Kolapo; Zahouli, Julien Z B; Fagbamigbe, Adeniyi Francis; de Souza, Dziedzom K; Dukhi, Natisha; Amankwaa, Ebenezer F; Tolba, Mai ; Sylverken, Augustina A; Mosi, Lydia; Mante, Priscilla Kolibea; Matoke-Muhia, Damaris; Goonoo, Nowsheen |
| Mar-2019 | Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients' response to cancer immunotherapy | Omar, Hany A; Tolba, Mai |
| Mar-2022 | The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model | Mahmoud, Mohamed; Abdollah, Maha R A; Elsesy, Mohamed E; Abou El Ella, Dalal ; Zada, Suher K; Tolba, Mai |
| 5-Jan-2022 | The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats | Habib, Christine N; Tadros, Mariane G; Tolba, Mai ; Menze, Esther ; Masoud, Somia I; Mohamed, Mohamed R |
